Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.ejphar.2003.10.041
DC Field | Value | |
---|---|---|
dc.title | Effect of nitric oxide releasing paracetamol and flurbiprofen on cytokine production in human blood | |
dc.contributor.author | Marshall, M. | |
dc.contributor.author | Moore, P.K. | |
dc.date.accessioned | 2014-11-20T05:58:28Z | |
dc.date.available | 2014-11-20T05:58:28Z | |
dc.date.issued | 2004-01-12 | |
dc.identifier.citation | Marshall, M., Moore, P.K. (2004-01-12). Effect of nitric oxide releasing paracetamol and flurbiprofen on cytokine production in human blood. European Journal of Pharmacology 483 (2-3) : 317-322. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ejphar.2003.10.041 | |
dc.identifier.issn | 00142999 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/108061 | |
dc.description.abstract | Exposure of anti-coagulated human blood to Escherichia coli lipopolysaccharide (50 ng/ml) resulted in the time-dependent (maximum at 5 h) biosynthesis of interleukin-1β and tumour necrosis factor-α (TNF-α). Preincubation with nitroparacetamol or nitroflurbiprofen (but not paracetamol or flurbiprofen) caused dose-related inhibition of the formation of interleukin 1β (IC50s, 44.5 and 362 μM, n=12) and tumour necrosis factor-α (IC50s, 9.0 and 0.0009 μM, n=12). The inhibitory effect of nitroparacetamol was completely reversed by (2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide; 2-(4-carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidazol-1-yloxy-3-oxide potassium (carboxy-PTIO, 100 μM; NO scavenging agent). Neither the nuclear factor-κB transduction inhibitor, pyrrolidinedithiocarbamate (10-1000 μM) nor the nitric oxide donor, 1-hydroxy-2-oxo-3-(3-aminopropyl)-3- isopropyl-1-triazene (NOC-5, 10-1000 μM), affected cytokine formation in these experiments. © 2003 Elsevier B.V. All rights reserved. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ejphar.2003.10.041 | |
dc.source | Scopus | |
dc.subject | Blood | |
dc.subject | Interleukin-1β | |
dc.subject | Lipopolysaccharide | |
dc.subject | Nitroflurbiprofen | |
dc.subject | Nitroparacetamol | |
dc.subject | TNF-α (tumour necrosis factor-α) | |
dc.type | Article | |
dc.contributor.department | PHARMACOLOGY | |
dc.description.doi | 10.1016/j.ejphar.2003.10.041 | |
dc.description.sourcetitle | European Journal of Pharmacology | |
dc.description.volume | 483 | |
dc.description.issue | 2-3 | |
dc.description.page | 317-322 | |
dc.description.coden | EJPHA | |
dc.identifier.isiut | 000188610600028 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.